Companies Sanara MedTech Inc.
Sanara MedTech (SMTI): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Sanara MedTech Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $2,306,511FY2025
CEO total pay was $2,306,511 in fiscal 2025; the brief holds no earlier figure for this CEO.
FY2025: salary $478,903 · bonus $472,000 · stock awards $1,318,742 · option awards $0
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Seth Yon | $478,903 | $472,000 | $1,318,742 | $0 | $0 | $0 | $36,866 | $2,306,511 |
| President and Chief Executive Officer | ||||||||
| Jacob Waldrop | 315,000 | 234,000 | 306,244 | 0 | 0 | 0 | 12,600 | 867,844 |
| Chief Operating Officer | ||||||||
| Suresh Muppalla | 612,794 | 0 | 103,014 | 0 | 0 | 0 | 0 | 715,808 |
| Former President and Chief Executive Officer of Tissue Health Plus, LLC | ||||||||
| Elizabeth Taylor | 240,545 | 209,000 | 187,509 | 0 | 0 | 0 | 0 | 637,054 |
| Chief Financial Officer | ||||||||
| Ronald Nixon | 247,994 | 0 | 262,485 | 0 | 0 | 0 | 75,000 | 585,479 |
| Former Chief Executive Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Seth Yon | $2,306,511 | — | — | — |
| Jacob Waldrop | 867,844 | 518,219 | — | ↑ +349,625 |
| Suresh Muppalla | 715,808 | — | — | — |
| Elizabeth Taylor | 637,054 | — | — | — |
| Ronald Nixon | 585,479 | 855,758 | — | ↓ −270,279 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The intent of the compensation program is to align executives' interests with those of shareholders while providing reasonable and competitive compensation. Executive compensation typically consists of base salary, annual cash bonus, and longer-term incentive compensation of equity-based incentive awards.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Elizabeth Taylor | RSU | 5,382 | — | $125,670 |
| Ronald Nixon | RSU | 7,534 | — | 175,919 |
| Jacob Waldrop | RSU | 10,341 | — | 241,462 |
| Seth Yon | RSU | 70,254 | — | 1,640,431 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Ann Beal SalamoneNot independent | $40,000 | $87,051 | — | — | $177,697 | $304,748 |
| Robert A. DeSutterIndependent · Audit Committee · Nominating and Corporate Governance Committee (Chair) · Corporate Development Committee (Chair) | 40,000 | 116,089 | — | — | 0 | 156,089 |
| Eric D. TanzbergerIndependent · Audit Committee (Chair) · Corporate Development Committee | 40,000 | 111,254 | — | — | 0 | 151,254 |
| Roszell Mack IIIIndependent · Audit · Compensation | 40,000 | 106,389 | — | — | 0 | 146,389 |
| Eric D. MajorIndependent · Compensation Committee · Nominating and Corporate Governance Committee · Corporate Development Committee | 40,000 | 101,554 | — | — | 0 | 141,554 |
| Sara N. OrtweinIndependent · Compensation Committee (Chair) · Nominating and Corporate Governance Committee | 40,000 | 101,554 | — | — | 0 | 141,554 |
| Keith G. MyersIndependent · Corporate Development Committee | 40,000 | 91,885 | — | — | 0 | 131,885 |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | $90,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 10,000 / 10,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $280,000 |
| Equity awards (grant-date value) | $715,776 |
| All other compensation | $177,697 |
| Total cost of the board | $1,173,473 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Sanara MedTech as a peer
Companies that benchmark against SMTI
No companies currently name SMTI as a compensation peer in their most recent disclosure.
This is the complete answer, not a partial one — the list is never padded.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Sanara MedTech Inc. | 2025 | Seth Yon | $478,903 | $1,318,742 | $0 | $0 | $2,306,511 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (15 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Seth Yon. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table” · page 26. As printed: 2,306,511. View filing ↗
- Section 01, Jacob Waldrop. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table” · page 26. As printed: 867,844. View filing ↗
- Section 01, Suresh Muppalla. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table” · page 26. As printed: 715,808. View filing ↗
- Section 01, Elizabeth Taylor. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table” · page 26. As printed: 637,054. View filing ↗
- Section 01, Ronald Nixon. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table” · page 26. As printed: 585,479. View filing ↗
- Section 08, Ann Beal Salamone. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 304,748. View filing ↗
- Section 08, Robert A. DeSutter. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 156,089. View filing ↗
- Section 08, Eric D. Tanzberger. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 151,254. View filing ↗
- Section 08, Roszell Mack III. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 146,389. View filing ↗
- Section 08, Eric D. Major. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 141,554. View filing ↗
- Section 08, Sara N. Ortwein. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 141,554. View filing ↗
- Section 08, Keith G. Myers. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 131,885. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 280,000 + equity 715,776 + all other 177,697 = 1,173,473, summed across the director compensation table rows.
- Sanara MedTech Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Sanara MedTech Inc.'s own proxy. As printed: 2,306,511. View filing ↗